Literature DB >> 12242531

How promising is hematopoetic stem cell transplantation in multiple sclerosis?

Reinhard Hohlfeld.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12242531     DOI： 10.1007/s00415-002-0802-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  20 in total

Review 1.  Treatment of multiple sclerosis: recent trials and future perspectives.

Authors:  J H Noseworthy; R Gold; H P Hartung
Journal:  Curr Opin Neurol       Date:  1999-06       Impact factor: 5.710

2.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 3.  Fifty ways to make a neuron: shifts in stem cell hierarchy and their implications for neuropathology and CNS repair.

Authors:  Marius Wernig; Oliver Brüstle
Journal:  J Neuropathol Exp Neurol       Date:  2002-02       Impact factor: 3.685

4.  Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.

Authors:  M A Eglitis; E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation.

Authors:  H H Euler; A M Marmont; A Bacigalupo; S Fastenrath; P Dreger; M Hoffknecht; A R Zander; B Schalke; U Hahn; R Haas; N Schmitz
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

7.  Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

Authors:  G Comi; L Kappos; M Clanet; G Ebers; A Fassas; F Fazekas; M Filippi; H P Hartung; B Hertenstein; D Karussis; G Martino; A Tyndall; F G van der Meché
Journal:  J Neurol       Date:  2000-05       Impact factor: 4.849

Review 8.  The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

Authors:  R Hohlfeld; M Kerschensteiner; C Stadelmann; H Lassmann; H Wekerle
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

9.  BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

Authors:  Christine Stadelmann; Martin Kerschensteiner; Thomas Misgeld; Wolfgang Brück; Reinhard Hohlfeld; Hans Lassmann
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

10.  Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

Authors:  M Kerschensteiner; E Gallmeier; L Behrens; V V Leal; T Misgeld; W E Klinkert; R Kolbeck; E Hoppe; R L Oropeza-Wekerle; I Bartke; C Stadelmann; H Lassmann; H Wekerle; R Hohlfeld
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307
View more
  1 in total

Review 1.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.